Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

188.17
Delayed Data
As of 4:00pm ET
 +1.85 / +0.99%
Today’s Change
133.64
Today|||52-Week Range
191.10
+28.70%
Year-to-Date
Novartis Poised to Grow on Oncology Portfolio & Biosimilars
3:07pm / Zacks.com - Paid Partner Content
Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle
Sep 16 / TheStreet.com - Paid Partner Content
Pfizer takes on J&J with antitrust lawsuit
1:11pm / FT.com - Paid Partner Content
Top Research Reports for Philip Morris, Amgen & Union Pacific
Sep 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised ...
9:18am / Zacks.com - Paid Partner Content
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Is Amgen (AMGN) a Great Stock for Value Investors?
Sep 19 / Zacks.com - Paid Partner Content
FDA Approves First 'Biosimilar' for Cancer Treatment
Sep 14 / TheStreet.com - Paid Partner Content
Novartis Announces Positive Data on Urticaria Drug Xolair
Sep 18 / Zacks.com - Paid Partner Content
Biosimilar 2017 Progress Report: Stocks in Focus
Sep 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close186.32
Today’s open186.08
Day’s range185.42 - 188.55
Volume2,633,282
Average volume (3 months)2,991,524
Market cap$136.0B
Dividend yield2.44%
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.82%
Earnings growth (next 5 years)+3.73%
Revenue growth (last year)+6.31%
P/E ratio17.1
Price/Sales4.86
Price/Book4.60

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.35+0.43%
BIIBBiogen+1.07+0.34%
ILMNIllumina Inc-1.86-0.91%
KITEKite Pharma Inc+0.24+0.13%
Data as of 4:14pm ET, 09/20/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts